土耳其将从中国购买2000万剂新冠肺炎疫苗,也与辉瑞洽谈

2020-11-19 15:32

Turkey to buy 20 million Covid-19 vaccine doses from China, also talking to Pfizer taA世界播

土耳其将从中国购买2000万剂新冠肺炎疫苗,也与辉瑞洽谈taA世界播


暂无taA世界播

Turkey's health minister Fahrettin Koca said a contract will be signed on this in one or two days. taA世界播

土耳其卫生部长法赫雷廷·科卡(Fahrettin Koca)表示,相关合同将在一两天内签署taA世界播


ANKARA (REUTERS) - Turkey will sign a contract within days to buy some 20 million doses of Covid-19 vaccine from China's Sinovac Biotech, Health Minister Fahrettin Koca told Parliament. taA世界播

路透安卡拉3月22日-土耳其卫生部长法赫雷丁·科卡告诉议会,土耳其将在几天内签署合同,从中国的中国中创生物科技公司购买约2,000万剂新冠肺炎疫苗。taA世界播


The government is also in talks to buy a vaccine from Pfizer and BioNTech, the state-run Anadolu news agency quoted Mr Koca as saying late on Wednesday (Nov 18). taA世界播

国营阿纳多卢通讯社援引科卡周三晚些时候(11月18日)的话说,政府还在就从辉瑞和BioNTech购买疫苗进行谈判。taA世界播


"We will be able to procure at least 10 million doses of the Chinese vaccine in December. We want to increase this number. It will be just as much in January, too," he said. taA世界播

他说:“我们将能够在12月采购至少1000万剂中国疫苗。我们希望增加这个数字。明年1月也会有同样的数量。”taA世界播


"This figure can easily double, probably. A contract will be signed on this in one or two days," he said at his ministry's budget presentation in Parliament. taA世界播

“这个数字可能很容易翻一番。一到两天内就会签署合同,”他在议会的财政部预算报告上说。taA世界播


Sinovac's experimental Covid-19 vaccine CoronaVac triggered a quick immune response, but the level of antibodies produced was lower than in people who recovered from the virus, preliminary trial results showed on Wednesday. taA世界播

周三的初步试验结果显示,Sinovac的实验性新冠肺炎疫苗CoronaVac引发了快速免疫反应,但产生的抗体水平低于病毒恢复者。taA世界播


CoronaVac and four other experimental vaccines developed in China are in late-stage trials to determine their effectiveness. taA世界播

中国开发的CoronaVac和其他四种实验性疫苗正在进行后期试验,以确定它们的有效性。taA世界播


The report follows upbeat news this month from Pfizer and Moderna, as well as Russia, that showed their experimental vaccines were over 90 per cent effective based on interim data from large, late-stage trials. taA世界播

在这份报告发布之前,辉瑞(Pfizer)、现代(Modern Na)以及俄罗斯本月传出的乐观消息显示,根据大型后期试验的中期数据,他们的实验疫苗有效率超过90%。taA世界播


Pfizer and BioNTech may secure emergency US and European authorisation for their Covid-19 vaccine next month after final trial results showed it had a 95 per cent success rate and no serious side effects, the drug-makers said on Wednesday. taA世界播

辉瑞(Pfizer)和生物科技(BioNTech)周三表示,在最终试验结果显示其新冠肺炎疫苗成功率为95%,且没有严重副作用后,这两家公司下月可能获得美国和欧洲的紧急批准。taA世界播


Mr Koca said Turkey was in talks to buy Pfizer's vaccine as wellonce it obtained its licence. taA世界播

科卡表示,一旦辉瑞获得许可证,土耳其也在洽谈购买辉瑞的疫苗。taA世界播


"If so, the number that can be given to Turkey is one million. We have talks right now to gradually go up to 25 million within the year starting from January," Mr Koca was quoted as saying. taA世界播

报道援引科卡的话说:“如果是这样的话,可以提供给土耳其的数量是100万。我们现在正在谈判,从明年1月开始的一年内逐步增加到2500万。”taA世界播

© 2016 世界播 www.shijiebobao.com 中国互联网举报中心 京ICP证140141号 鄂ICP备18018000号-1
违法和不良信息举报: